Lumos Pharma Inc.

NASDAQ: LUMO · Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM

Lumos Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.76 -0.97 -1.9
PEG Ratio
-0.06 -0.59 -0.01
PS Ratio
12.63 19.85 251.12
PB Ratio
0.95 0.51 0.65
P/FCF Ratio
-0.83 -1.13 -1.95
P/OCF Ratio
-0.83 -1.14 -1.95
OCF/S Ratio
-15.16 -17.48 -128.9
Debt / Equity Ratio
0.02 0.00 0.01
Quick Ratio
5.69 10.73 19.43
Current Ratio
5.69 10.73 19.43
Asset Turnover
0.05 0.02 0.00
Interest Coverage
n/a n/a n/a
Return on Equity
-1.25 -0.52 -0.34
Return on Assets
-0.84 -0.43 -0.3
Return on Invested Capital
-1.07 -0.48 -0.32
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
1.00 0.97 1.00
Net Profit Margin
-16.59 -20.4 -132.3
Pretax Profit Margin
-16.61 -20.4 -135.07
Operating Profit Margin
-17.85 -21.04 -136.29
FCF Margin
n/a n/a n/a
EBITDA Margin
-17.83 -21.01 -135.35